Redeye comments on the rights issue announced today and the new study design. We revise our base case based on the new path to market and dilution expected from the rights issue.
ANNONS
Redeye comments on the rights issue announced today and the new study design. We revise our base case based on the new path to market and dilution expected from the rights issue.